Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy

Ocular Immunology and Inflammation
Wantanee SittivarakulTippawan Liabsuetrakul

Abstract

To calculate the incidence of, and to identify the risk factors for developing contralateral eye involvement among patients with AIDS and unilateral cytomegalovirus retinitis (CMV retinitis), who were treated, in the era of highly-active antiretroviral therapy (HAART), with repetitive intravitreal ganciclovir injections. The clinical records of 119 patients were included. The main outcome measurement was the occurrence of contralateral eye involvement. Over a mean follow-up period of 1.6 years, the overall incidence rate of contralateral involvement was 0.17/person-year. The cumulative incidence of contralateral involvement at 6 months and 1 year was 23.8% and 28.4%, respectively. Receiving HAART at the visit before the event was associated with a decreased risk of developing contralateral retinitis (hazard ratio [HR] = 0.26, P = 0.002). The use of HAART, associated with subsequent immune recovery, significantly reduced the incidence of contralateral eye involvement by approximately 75% among patients in our setting.

References

Sep 1, 1984·Ophthalmology·A G PalestineR Steis
Aug 1, 1983·Ophthalmology·G N HollandR Y Foos
Feb 1, 1984·American Journal of Ophthalmology·W R FreemanM L Tapper
Aug 1, 1997·American Journal of Ophthalmology·D A Jabs, J G Bartlett
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A JacobsonE T Cunningham
Apr 12, 2002·The New England Journal of Medicine·Daniel F MartinUNKNOWN Valganciclovir Study Group
Jan 14, 2003·Archives of Ophthalmology·Janet T HolbrookUNKNOWN Studies of Ocular Complications of AIDS (SOCA) Research Group
Oct 30, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H KempenJames Tonascia
Dec 8, 2004·Ophthalmology·Douglas A JabsUNKNOWN Studies of Ocular Complications of AIDS Research Group
Aug 3, 2010·Ophthalmology·Douglas A JabsUNKNOWN Studies of the Ocular Complications of AIDS Research Group
Aug 25, 2011·American Journal of Ophthalmology·Somsanguan AusayakhunTodd P Margolis
Jan 24, 2012·American Journal of Ophthalmology·Somsanguan AusayakhunTodd P Margolis
Feb 20, 2013·Ophthalmology·Douglas A JabsUNKNOWN Studies of the Ocular Complications of AIDS Research Group

❮ Previous
Next ❯

Citations

Aug 23, 2019·Chinese Medical Journal·Xin-Yan Zhang, Feng Fang
Mar 23, 2017·Ocular Immunology and Inflammation·Wantanee Sittivarakul, Usanee Seepongphun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses
R J CampbellWilliam G Hodge
American Journal of Ophthalmology
Elizabeth A SugarStudies of the Ocular Complications of AIDS Research Group
© 2021 Meta ULC. All rights reserved